Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A <scp>MASK</scp> ‐air and <scp>EAACI</scp> Methodological Committee Report

Using patient-reported data, we evaluated different medication classes and treatments in terms of satisfaction and co-medication frequency. These results provide key insights into the acceptability of AR treatments and will contribute to future treatment guidelines.

Authors

Institutions

Publication Details

Journal
Allergy
Published
2025-09-26
DOI
https://doi.org/10.1111/all.70055
Citations
3
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
4.87

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK ‐air and EAACI Methodological Committee Report

Leticia de las Vecillas, Ana Margarida Pereira, Torsten Zuberbier, João Coutinho‐Almeida et al.
3 citations
Allergy
Allergic Rhinitis and Sensitization
4.87
article

Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK ‐air and EAACI Methodological Committee Report

Leticia de las Vecillas, Ana Margarida Pereira, Torsten Zuberbier, João Coutinho‐Almeida, Bilun Gemicioğlu, Ilgım Vardaloğlu, Mattia Giovannini, Sara Gil‐Mata, Yi‐Kui Xiang, Rafael José Vieira, Tuuli Thomander, Bernardo Sousa‐Pinto, Giorgio Walter Canonica, Juan Carlos Ivancevich, Oliver Pfaar, Matteo Martini, Marek Niedoszytko, Désirée Larenas‐Linnemann, Ludger Klimek, Jolanta Walusiak‐Skorupa, Luís Taborda‐Barata, Antonio Bognanni, Violeta Kvedarienė, Rita Amaral, Manuel Marques‐Cruz, Danilo Di Bona, Andre M. Moreira, Álvaro Augusto Cruz, N. Pham‐Thi, Holger J. Schünemann, Michał Ordak, Frederico S. Regateiro, Maria Teresa Ventura, João Fonseca, J. Sastre, Giovanni Paoletti, Nikolaos G. Papadopoulos, Anna Bedbrook, Patrizia Bonadonna, Sanna Toppila‐Salmi, Arūnas Valiulis, Mark S. Dykewicz, Luisa Brussino, Boleslaw Samolinski
article en
3 citations

Abstract

Using patient-reported data, we evaluated different medication classes and treatments in terms of satisfaction and co-medication frequency. These results provide key insights into the acceptability of AR treatments and will contribute to future treatment guidelines.

AllergyVol. 80(12)
University of Foggia (IT), Tongji University (CN), University of Verona (IT), Marche Polytechnic University (IT), Uppsala University (SE), Universidade Federal da Bahia (BR), Fundação de Amparo à Pesquisa do Estado da Bahia (BR), University of Helsinki (FI), Humanitas University (IT), École Polytechnique (FR), Philipps University of Marburg (DE), University of Beira Interior (PT), Vilnius University (LT), University of Eastern Finland (FI), Universidade do Porto (PT), Johannes Gutenberg University Mainz (DE), National and Kapodistrian University of Athens (GR), Université Paris Cité (FR), Nofer Institute of Occupational Medicine (PL), Medical University of Warsaw (PL), Helsinki University Hospital (FI), Instituto de Salud Carlos III (ES), Hospitais da Universidade de Coimbra (PT), Hospital Center of Cova da Beira (PT), Hospital de São João (PT), Humboldt-Universität zu Berlin (DE), Vilnius University of Applied Sciences (LT), Hospital Médica Sur (MX), Hospital La Paz Institute for Health Research (ES), Fraunhofer Institute for Translational Medicine and Pharmacology (DE), Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie (DE), Istanbul University-Cerrahpaşa (TR), CUF Porto Hospital (PT), Meyer Children's Hospital (IT), Zentrum für Rhinologie und Allergologie (DE), Institut de Médecine Tropicale du Service de Santé des Armées (FR), A. O. Ordine Mauriziano di Torino (IT), Hospital Universitario Fundación Jiménez Díaz (ES), Institute of Sciences of Food Production (IT), Institut Hospitalier Franco Britannique (FR), Centre for Health Technology and Services Research (PT), Laboratoire d'Informatique de l'École Polytechnique (FR), National Research Council (IT), Shanghai Skin Disease Hospital (CN), i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto (PT), Cochrane (CA), IRCCS Humanitas Research Hospital (IT), University of Florence (IT), Saint Louis University (US), University of Turin (IT), University of Bari Aldo Moro (IT), Universidad Autónoma de Madrid (ES), Istanbul University (TR), Gdańsk Medical University (PL), University of Coimbra (PT), Polytechnic Institute of Porto (PT), McMaster University (CA)
Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Teva Pharmaceutical Industries, Celldex Therapeutics, Mylan, Universidad de Especialidades Espíritu Santo, Celltrion, Korvatautien Tutkimussäätiö, Astellas Pharma, Université de Liège, Hengityssairauksien Tutkimussäätiö, Filha, European Academy of Allergy and Clinical Immunology, Horizon 2020 Framework Programme, HORIZON EUROPE Framework Programme, Directorate-General for Communications Networks, Content and Technology
Openalex Percentile: Top 5%
Allergic Rhinitis and Sensitization
4.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.